Lincoln Pharmaceuticals Limited LINCOLN.NS Stock
Lincoln Pharmaceuticals Limited Price Chart
Lincoln Pharmaceuticals Limited LINCOLN.NS Financial and Trading Overview
Lincoln Pharmaceuticals Limited stock price | 599 INR |
Previous Close | 392.15 INR |
Open | 392.9 INR |
Bid | 387.05 INR x 0 |
Ask | 387.45 INR x 0 |
Day's Range | 386.05 - 394 INR |
52 Week Range | 270 - 456.3 INR |
Volume | 59.82K INR |
Avg. Volume | 132.76K INR |
Market Cap | 7.78B INR |
Beta (5Y Monthly) | 0.52226 |
PE Ratio (TTM) | 10.756186 |
EPS (TTM) | 43.55 INR |
Forward Dividend & Yield | 1.5 (0.38%) |
Ex-Dividend Date | September 15, 2022 |
1y Target Est | N/A |
LINCOLN.NS Valuation Measures
Enterprise Value | 6.58B INR |
Trailing P/E | 10.756186 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.5250936 |
Price/Book (mrq) | 1.5426451 |
Enterprise Value/Revenue | 1.289 |
Enterprise Value/EBITDA | 7.374 |
Trading Information
Lincoln Pharmaceuticals Limited Stock Price History
Beta (5Y Monthly) | 0.52226 |
52-Week Change | 33.97% |
S&P500 52-Week Change | 20.43% |
52 Week High | 456.3 INR |
52 Week Low | 270 INR |
50-Day Moving Average | 394.42 INR |
200-Day Moving Average | 340.6 INR |
LINCOLN.NS Share Statistics
Avg. Volume (3 month) | 132.76K INR |
Avg. Daily Volume (10-Days) | 129.48K INR |
Shares Outstanding | 20.03M |
Float | 7.63M |
Short Ratio | N/A |
% Held by Insiders | 65.77% |
% Held by Institutions | 0.032% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.5 |
Trailing Annual Dividend Yield | 0.38% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.041199997 |
Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 14.28% |
Operating Margin (ttm) | 15.68% |
Gross Margin | 52.69% |
EBITDA Margin | 17.48% |
Management Effectiveness
Return on Assets (ttm) | 8.91% |
Return on Equity (ttm) | 15.58% |
Income Statement
Revenue (ttm) | 5.1B INR |
Revenue Per Share (ttm) | 254.81 INR |
Quarterly Revenue Growth (yoy) | 9.59% |
Gross Profit (ttm) | 2.69B INR |
EBITDA | 892.03M INR |
Net Income Avi to Common (ttm) | 728.99M INR |
Diluted EPS (ttm) | 35.97 |
Quarterly Earnings Growth (yoy) | 14.00% |
Balance Sheet
Total Cash (mrq) | 1.26B INR |
Total Cash Per Share (mrq) | 62.71 INR |
Total Debt (mrq) | 19.97M INR |
Total Debt/Equity (mrq) | 0.4 INR |
Current Ratio (mrq) | 5.08 |
Book Value Per Share (mrq) | 250.803 |
Cash Flow Statement
Operating Cash Flow (ttm) | 392.62M INR |
Levered Free Cash Flow (ttm) | 211.52M INR |
Profile of Lincoln Pharmaceuticals Limited
Country | India |
State | N/A |
City | Ahmedabad |
Address | Lincoln House |
ZIP | 380060 |
Phone | 91 79 4107 8000 |
Website | https://www.lincolnpharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative, as well as dermatologist preparations, gynecological products, gastrointestinal rang, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics. The company was incorporated in 1979 and is based in Ahmedabad, India.
Q&A For Lincoln Pharmaceuticals Limited Stock
What is a current LINCOLN.NS stock price?
Lincoln Pharmaceuticals Limited LINCOLN.NS stock price today per share is 599 INR.
How to purchase Lincoln Pharmaceuticals Limited stock?
You can buy LINCOLN.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lincoln Pharmaceuticals Limited?
The stock symbol or ticker of Lincoln Pharmaceuticals Limited is LINCOLN.NS.
Which industry does the Lincoln Pharmaceuticals Limited company belong to?
The Lincoln Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Lincoln Pharmaceuticals Limited have in circulation?
The max supply of Lincoln Pharmaceuticals Limited shares is 20.03M.
What is Lincoln Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Lincoln Pharmaceuticals Limited PE Ratio is 13.75430600 now.
What was Lincoln Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Lincoln Pharmaceuticals Limited EPS is 43.55 INR over the trailing 12 months.
Which sector does the Lincoln Pharmaceuticals Limited company belong to?
The Lincoln Pharmaceuticals Limited sector is Healthcare.